| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.81B | -3.8% |
| Cost of Revenue | $1.45B | -0.1% |
| Gross Profit | $359.8M | -16.1% |
| R&D Expense | $27.5M | +1.5% |
| SG&A Expense | $230.7M | -3.0% |
| Operating Income | $27.5M | -73.2% |
| Pre-tax Income | -$34.3M | -163.6% |
| Income Tax | $35.8M | +269.1% |
| Net Income | -$70.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.7M | +37.3% |
| Accounts Receivable | $213.6M | +0.8% |
| Inventory | $277.3M | -4.5% |
| Current Assets | $643.8M | +5.0% |
| Total Assets | $1.91B | +2.7% |
| Current Liabilities | $626.4M | +21.2% |
| Long-term Debt | $674.5M | +4.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $215.8M | +72.2% |
| Investing Cash Flow | -$161.0M | +22.1% |
| Financing Cash Flow | -$41.2M | -146.1% |
| -258.6% |
| EPS (Basic) | -$1.24 | -263.2% |
| EPS (Diluted) | -$1.24 | -263.2% |
| Stockholders' Equity |
| $384.6M |
| -19.0% |